Inotuzumab ozogamicin and Insulin Glulisine (Vials)
Determining the interaction of Inotuzumab ozogamicin and Insulin Glulisine (Vials) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin-Insulin glulisine Subcutaneous
- Inotuzumab ozogamicin-Insulin human inhaled Inhalation
- Inotuzumab ozogamicin-Insulin human regular Injection
- Inotuzumab ozogamicin-Insulin inhalation
- Inotuzumab ozogamicin-Insulin isophane
- Inotuzumab ozogamicin-Insulin isophane and insulin regular
- Insulin Glulisine (Vials)-Inotuzumab ozogamicin Intravenous
- Insulin Glulisine (Vials)-Inova
- Insulin Glulisine (Vials)-Inova 4/1 topical
- Insulin Glulisine (Vials)-Inova 8/2 topical
- Insulin Glulisine (Vials)-Inova ACT
- Insulin Glulisine (Vials)-Inrebic